Your browser doesn't support javascript.
The added effect of non-pharmaceutical interventions and lifestyle behaviors on vaccine effectiveness against severe COVID-19 in Chile: A matched case-double control study.
Urquidi, Cinthya; Santelices, Emilio; Lagomarcino, Anne J; Teresa Valenzuela, María; Larrañaga, Nicolás; Gonzalez, Emilio; Pavez, Axel; Wosiack, Amanda; Maturana, Marcela; Moller, Paulina; Pablo Torres, Juan; Muñoz, Sergio; O'Ryan G, Miguel.
  • Urquidi C; Departamento de Epidemiología y Estudios en Salud, Facultad de Medicina, Universidad de Los Andes, Chile, Monseñor Álvaro del Portillo 1245, Las Condes, Santiago, Chile.
  • Santelices E; Escuela de Salud Pública, Facultad de Medicina, Universidad de Chile, Av. Independencia 939, Independencia, Santiago, Chile.
  • Lagomarcino AJ; Dirección de Innovación, Facultad de Medicina, Universidad de Chile, Av. Independencia 1027, Independencia, Santiago, Chile.
  • Teresa Valenzuela M; Departamento de Epidemiología y Estudios en Salud, Facultad de Medicina, Universidad de Los Andes, Chile, Monseñor Álvaro del Portillo 1245, Las Condes, Santiago, Chile.
  • Larrañaga N; Hospital El Carmen Dr. Luis Valentín Ferrada, Camino a Rinconada 1201, Avenida El Olimpo, Maipú, Santiago, Chile.
  • Gonzalez E; Hospital de Urgencia Asistencia Pública (HUAP), Curicó 345, Santiago, Chile; Universidad del Desarrollo, Facultad de Medicina Clinica Alemana, Avenida La Plaza 680, Las Condes, Santiago, Chile.
  • Pavez A; Hospital de Urgencia Asistencia Pública (HUAP), Curicó 345, Santiago, Chile.
  • Wosiack A; Hospital de Urgencia Asistencia Pública (HUAP), Curicó 345, Santiago, Chile.
  • Maturana M; Independent consultant.
  • Moller P; Cesfam Dr. José Eduardo Ahués, Independencia 2200, Maipú, Santiago, Chile.
  • Pablo Torres J; Dirección de Innovación, Facultad de Medicina, Universidad de Chile, Av. Independencia 1027, Independencia, Santiago, Chile; Departamento de Pediatría Oriente, Facultad de Medicina, Universidad de Chile, Av. Antonio Varas 360, Providencia, Santiago, Chile.
  • Muñoz S; Departamento de Salud Pública - CIGES, Facultad de Medicina, Universidad de La Frontera, Av. Francisco Salazar 01145, Temuco, Chile.
  • O'Ryan G M; Programa de Microbiología y Micología, Instituto de Ciencias Biomédicas, Facultad de Medicina, Av. Independencia 1027, Universidad de Chile, Independencia, Santiago, Chile; Instituto de Sistemas Complejos de Ingeniería (ISCI), Universidad de Chile, República 695, Santiago, Chile. Electronic address:
Vaccine ; 41(18): 2947-2955, 2023 05 02.
Article in English | MEDLINE | ID: covidwho-2284939
ABSTRACT

BACKGROUND:

World Health Organization approved vaccines have demonstrated relatively high protection against moderate to severe COVID-19. Prospective vaccine effectiveness (VE) designs with first-hand data and population-based controls are nevertheless rare. Neighborhood compared to hospitalized controls, may differ in compliance to non-pharmacuetical interventions (NPI) compliance, which may influence VE results in real-world settings. We aimed to determine VE against COVID-19 intensive-care-unit (ICU) admission using hospital and community-matched controls in a prospective design.

METHODS:

We conducted a multicenter, observational study of matched cases and controls (13) in adults ≧18 years of age from May to July 2021. For each case, a hospital control and two community controls were matched by age, gender, and hospital admission date or neighborhood of residence. Conditional logistic regression models were built, including interaction terms between NPIs, lifestyle behaviors, and vaccination status; the model's ß coefficients represent the added effect these terms had on COVID-19 VE.

RESULTS:

Cases and controls differed in several factors including education level, obesity prevalence, and behaviors such as compliance with routine vaccinations, use of facemasks, and routine handwashing. VE was 98·2% for full primary vaccination and 85·6% for partial vaccination when compared to community controls, and somewhat lower, albeit not significantly, compared to hospital controls. A significant added effect to vaccination in reducing COVID-19 ICU admission was regular facemask use and VE was higher among individuals non-compliant with the national vaccine program, and/or tonroutine medical visits during the prior year.

CONCLUSION:

VE against COVID-19 ICU admission in this stringent prospective case-double control study reached 98% two weeks after full primary vaccination, confirming the high effectiveness provided by earlier studies. Face mask use and hand washing were independent protective factors, the former adding additional benefit to VE. VE was significantly higher in subjects with increased risk behaviors.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Vaccine Efficacy Type of study: Etiology study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Humans Country/Region as subject: South America / Chile Language: English Journal: Vaccine Year: 2023 Document Type: Article Affiliation country: J.vaccine.2023.03.060

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Vaccine Efficacy Type of study: Etiology study / Experimental Studies / Observational study / Prognostic study Topics: Vaccines Limits: Adult / Humans Country/Region as subject: South America / Chile Language: English Journal: Vaccine Year: 2023 Document Type: Article Affiliation country: J.vaccine.2023.03.060